Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H8N2 |
| Molecular Weight | 60.0983 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCN
InChI
InChIKey=PIICEJLVQHRZGT-UHFFFAOYSA-N
InChI=1S/C2H8N2/c3-1-2-4/h1-4H2
Ethylenediamine is a strongly basic amine useful as a building block in chemical synthesis. It is used as a solvent to dissolve proteins such as albumins, casein and in medicine to stabilize aminophylline when used in injections. Ethylenediamine is used in manufacture of chelating agents (EDTA), epoxy curing agents, dimethylolethylene-urea resins, emulsifying agents, textile lubricants, antifreeze inhibitor. It is also involved in the manufacture of many industrial chemicals and forms derivatives with carboxylic acids, nitriles, alcohols, alkylating agents, carbon disulfide, aldehydes and ketones. It is a basic building block to prepare heterocyclic compound such as imidazolidines.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Kinetics and mechanisms of EDTA photocatalytic degradation with TiO2. | 2001 |
|
| [Effect of Na2H2EDTA on the viability of rats' organism during hypothermia]. | 2001 |
|
| Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. | 2001 |
|
| Biodegradable biocomposite non-woven matrices based on PDLLA- and elastin-solubilized proteins/elastin. | 2001 |
|
| Use of a new HemoCue system for measuring haemoglobin at low concentrations. | 2001 Apr |
|
| Prenatal HLA typing of uncultured amniocytes prior to the collection of related allogeneic cord blood. | 2001 Aug |
|
| Speciation of rare earth elements in soil by sequential extraction then HPLC coupled with visible and ICP-MS detection. | 2001 Aug |
|
| Hydrogen-bonded adducts of ferrocene-1,1'-diylbis(diphenylmethanol): monomeric and dimeric 1:1 adducts with 1,2-bis(4-pyridyl)ethane and 1,2-diaminoethane. | 2001 Aug |
|
| [H3N(CH2)2NH3]0.5[BePO4], a beryllophosphate analogue of aluminosilicate zeolite gismondine. | 2001 Aug |
|
| Biodegradability of ethylenediamine-based complexing agents and related compounds. | 2001 Aug |
|
| Synthesis and structure of [K(+)-(2,2)diaza-[18]-crown-6][K3Ge9]-2ethylenediamine: stabilization of the two-dimensional layer (2)(infinity)[K3Ge9(1-)]. | 2001 Aug 27 |
|
| Secretion of a trypsin-like thiol protease by a new keratinolytic strain of Bacillus licheniformis. | 2001 Dec 18 |
|
| Yield and post-yield behavior of mussel byssal thread: a self-healing biomolecular material. | 2001 Fall |
|
| Potential energy surface crossings and the mechanistic spectrum for intramolecular electron transfer in organic radical cations. | 2001 Jan 31 |
|
| [Effect of calcium ion level in blood on physiological functions in rat subjected to immersion hypothermia]. | 2001 Jul |
|
| Preparation of a ribonucleic acid-(polyamidoamine)-(zirconia-urea-formaldehyde resin) high-performance liquid affinity chromatographic stationary phase. | 2001 Jul |
|
| Tetranuclear mixed-metal M(II)2Cu(II)2 complexes derived from a phenol-based macrocyclic ligand having two N(amine)2O2 and two N(imine)2O2 metal-binding sites. | 2001 Jul 16 |
|
| Rabbit M cells and dome enterocytes are distinct cell lineages. | 2001 Jun |
|
| Optimized aminolysis conditions for cleavage of N-protected hydrophobic peptides from solid-phase resins. | 2001 Jun |
|
| Chemoenzymatic synthesis of sucrose-containing aromatic polymers. | 2001 Mar 5 |
|
| Catalysis and inhibition of ligand substitution in palladium(II) square-planar complexes: effects of DNA. | 2001 Mar 7 |
|
| [Effect of alpha-lipoic acid preparations on bilirubin and transferrin levels and ferritin iron and transferrin iron content]. | 2001 Mar-Apr |
|
| A three-dimensional porous framework complex, poly[[bis(ethylenediamine)copper(II)] [potassium hexacyanocobalt(III)]]. | 2001 Nov |
|
| Plane-wave density functional theoretic study of formation of clay-polymer nanocomposite materials by self-catalyzed in situ intercalative polymerization. | 2001 Nov 28 |
|
| Gold-gold interactions as crystal engineering design elements in heterobimetallic coordination polymers. | 2001 Nov 5 |
|
| Polar nitrogen compounds and their behaviour in the drinking water treatment process. | 2001 Oct |
|
| Predictive value of chromatin decondensation in vitro on fertilization rate after intracytoplasmic sperm injection (ICSI). | 2001 Oct |
|
| The effect of pH and concentration upon aggregation transitions in aqueous solutions of poloxamine T701. | 2001 Oct 23 |
|
| Inhibition of cancer cell growth by ruthenium(II) arene complexes. | 2001 Oct 25 |
|
| Layered cobalt hydroxysulfates with both rigid and flexible organic pillars: synthesis, structure, porosity, and cooperative magnetism. | 2001 Oct 31 |
|
| Design of oxytocin antagonists, which are more selective than atosiban. | 2001 Sep |
|
| Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity. | 2001 Sep |
|
| Aminoethylethanolamine: a new allergen in cosmetics? | 2001 Sep |
|
| Syntheses, vibrational spectra, and theoretical studies of the adamantanoid Sn(4)Ch(10)(4-) (Ch = Se, Te) anions: X-ray crystal structures of [18-crown-6-K](4)[Sn4Se10]*5en and [18-crown-6-K](4)[Sn4Te10]*3en*2THF. | 2001 Sep 10 |
|
| Utilization of quinolone drugs as monomers: characterization of the synthesis reaction products for poly(norfloxacin diisocyanatododecane polycaprolactone). | 2001 Spring |
|
| [Occupational asthma due to amines]. | 2002 Feb |
|
| Experimental studies on the nature of bonding of DNA*bipyridyl-(ethylenediamine)platinum(II) and DNA*netropsin complexes in solution and oriented wet-spun films. | 2002 Feb |
|
| Bis(ethylenediamine)copper(II) bis(O,O'-diethyl dithiophosphate). | 2002 Feb |
|
| Molecular characteristics of glnA linked mutations in the nitrogen-fixing cyanobacterium Nostoc muscorum. | 2002 Feb |
|
| Schiff bis bases: analytical reagents. II. Spectrophotometric determination of manganese from pharmaceutical forms. | 2002 Feb 1 |
|
| c-erbB-2 is not a major factor in the development of colorectal cancer. | 2002 Feb 12 |
|
| Structure-directing coordination template effect of ethylenediamine in formations of ZnS and ZnSe nanocrystallites via solvothermal route. | 2002 Feb 25 |
|
| Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide. | 2002 Jan |
|
| Galactosylated alginate as a scaffold for hepatocytes entrapment. | 2002 Jan |
|
| Development of preparation methods for and insights obtained from atomic force microscopy of fluid spaces in cortical bone. | 2002 Jan-Feb |
|
| Direct synthesis of peptides on convective interaction media monolithic columns for affinity chromatography. | 2002 Jan-Feb |
|
| Three different bonding modes of cyano groups in the coordination polymer [Cu(en)2(H(2)O)][Cu(en)(2)Ni(2)Cu(2)(CN)(10)] x 2H(2)O (en is 1,2-diaminoethane). | 2002 Mar |
|
| Designed self-assembly of molecular necklaces. | 2002 Mar 13 |
|
| Role of magnesium in nucleotide exchange on the small G protein rac investigated using novel fluorescent Guanine nucleotide analogues. | 2002 Mar 19 |
|
| [Ph(2)Bi-(Ge(9))-BiPh(2)](2-): a deltahedral Zintl ion functionalized by exo-bonded ligands. | 2002 Mar 20 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
||
|
EPA PESTICIDE CODE |
4205
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
||
|
CFR |
21 CFR 173.320
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4158
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
7141
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
m5119
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB14189
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL816
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
3301
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
60V9STC53F
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
203-468-6
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
30347
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
SUB13760MIG
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
107-15-3
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
ETHYLENEDIAMINE
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
60V9STC53F
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000184306
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
DTXSID5021881
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
C80898
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
100000092194
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
535
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 17:33:06 GMT 2025 , Edited by admin on Mon Mar 31 17:33:06 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
